1-800 Contacts in talks for buyout

Article

As brick and mortars stores struggle, 1-800 Contacts surges

KKR & Co. Inc is in advanced talks to buy 1-800 Contacts, the largest retailer of contact lenses in the U.S., from investment firm AEA Investors LP, in a deal worth more than $3 billion.

According to Bloomberg News, sources familiar with the acquisition reported KKR beat out rival private equity firms in an auction for the contact lens retailer.1 The decision is not yet public, and talks could still fall through.

1-800 Contacts started in a dorm room in 1995, according to the company. The company was traded on Nasdaq for about a decade before being bought by private-equity firm Fenway Partners in 2007. When the COVID-19 pandemic began, it saw enormous growth and a surge of sales as consumers left brick-and-mortar stores for online alternatives.

The optometric community and the U.S. Food and Drug Administration (FDA) have been at odds with online glasses and contact lens retailers, including 1-800 Contacts, for years because of public health concerns with counterfeit products being sold.

See more: FDA authorizes first COVID-19 point-of-care antibody test

ODs weigh in

Optometry Times® asked optometrists about the acquisition and found that public health topped their list of concerns. Editorial Advisory Board member David I. Geffen, OD, FAAO, warns ODs of the dangers facing eye care and suggests stressing the value of comprehensive eye exams to patients thinking of ordering online.

“The advent of private equity money coming into eye care is going to make the product side of the business more competitive than ever,” Geffen says. “Independent doctors need to provide value for service and make sure their patients realize what they are getting from them instead of just ordering from a bot!”

Editorial Advisory Board member Mile Brujic, OD, FAAO, stresses the importance of patient healthcare needs and not business profitability.

“Healthcare providers make business decisions in their offices based on improving patient care; businesses look for opportunities in health care and at times prioritize profitability ahead of patient care,” Brujic says. “We hope that the acquisition is a responsible one that places patient’s healthcare needs first."

Related: 1-800 Contacts ramps up legislative fights

See more: Brain stimulation can reduce the effects of macular degeneration

Reference

1. Ahmed N, Porter K, Tse C. KKR nears $3 billion-plus deal to buy 1-800 Contacts. Bloomberg. Available at: https://www.bloomberg.com/news/articles/2020-09-22/kkr-said-to-near-3-billion-plus-deal-to-buy-1-800-contacts. Accessed 9/23/20.

Recent Videos
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
Clark Chang, OD, MSA, MSc, FAAO, discussed the complexities of diagnosing keratoconus in his Rapid Fire presentation given at the American Academy of Optometry 2024 meeting.
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, details the ease of genetic testing when diagnosing patients or reassessing a patient's diagnosis.
Gromacki, OD, FAAO, FSLS, emphasizes that corneal GP lenses remain an important part of a contact lens specialist's armamentarium
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, discusses diagnostic confusion that can be encountered when identifying macular edema in patients.
© 2024 MJH Life Sciences

All rights reserved.